Work

Treatment of epistaxis in Osler-Weber-Rendu disease by bevacizumab nasal spray. The EROSB study: Determining the effective dose

Year: 2024

Type: article

Study design: Clinical Trial

Source: European Annals of Otorhinolaryngology Head and Neck Diseases

DOI: 10.1016/j.anorl.2024.10.006

Authors: L. Vincent, L. Robard, C. Creveuil, E. Babin, M. Perreard, M. Humbert

Institutions: Centre Hospitalier Universitaire de Caen Normandie, Centre Hospitalier Universitaire de Nantes

Language: English

Topic: Vascular Anomalies and Treatments

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4404109011

FWCI: 1.129

Cites: 26

Cited by: 3

Related to: 10